Current
0.3×
5-Year Average
0.5×
All-Time High
0.8×
All-Time Low
0.1×
P/S Ratio daily chart for Humana (HUM)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/S Ratio for Humana (HUM) from 2001 to 2025
| 2025 | $30.82B | $129.66B | 0.2× | -0.0× | |
| 2024 | $30.55B | $117.76B | 0.3× | -0.3× | |
| 2023 | $56.06B | $106.37B | 0.5× | -0.2× | |
| 2022 | $64.35B | $92.87B | 0.7× | -0.0× | |
| 2021 | $59.66B | $84.09B | 0.7× | +0.0× | |
| 2020 | $54.19B | $77.16B | 0.7× | -0.0× | |
| 2019 | $48.55B | $64.93B | 0.7× | +0.1× | |
| 2018 | $39.12B | $56.91B | 0.7× | +0.0× | |
| 2017 | $35.06B | $53.77B | 0.7× | +0.1× | |
| 2016 | $30.51B | $54.38B | 0.6× | +0.1× | |
| 2015 | $26.59B | $54.29B | 0.5× | +0.0× | |
| 2014 | $21.79B | $48.50B | 0.4× | +0.1× | |
| 2013 | $16.10B | $41.31B | 0.4× | +0.1× | |
| 2012 | $10.90B | $39.13B | 0.3× | -0.1× | |
| 2011 | $14.30B | $36.83B | 0.4× | +0.1× | |
| 2010 | $9.14B | $33.67B | 0.3× | +0.0× | |
| 2009 | $7.36B | $30.96B | 0.2× | +0.0× | |
| 2008 | $6.21B | $28.95B | 0.2× | -0.3× | |
| 2007 | $12.64B | $25.29B | 0.5× | +0.1× | |
| 2006 | $9.14B | $21.42B | 0.4× | -0.2× | |
| 2005 | $8.69B | $14.42B | 0.6× | +0.2× | |
| 2004 | $4.70B | $13.10B | 0.4× | +0.1× | |
| 2003 | $3.68B | $12.23B | 0.3× | +0.1× | |
| 2002 | $1.79B | $11.26B | 0.2× | -0.0× | |
| 2001 | $1.98B | $10.15B | 0.2× | — |
- 20250.2×
- 20240.3×
- 20230.5×
- 20220.7×
- 20210.7×
- 20200.7×
- 20190.7×
- 20180.7×
- 20170.7×
- 20160.6×
- 20150.5×
- 20140.4×
- 20130.4×
- 20120.3×
- 20110.4×
- 20100.3×
- 20090.2×
- 20080.2×
- 20070.5×
- 20060.4×
- 20050.6×
- 20040.4×
- 20030.3×
- 20020.2×
- 20010.2×
About P/S Ratio at Humana (HUM)
Humana (HUM) P/S ratio is 0.3× as of June 5, 2026. The 5-year average is 0.5×. The sector median currently stands at 3.5×. The current ratio is at the 32th percentile of its own 10-year history.
Humana (HUM) historical P/S ratio has ranged from a low of 0.1× (2003) to a high of 0.8× (2018) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
Humana P/S Ratio by Year
Humana P/S Ratio 2025: 0.2×
Humana (HUM) P/S ratio in 2025 was 0.2×, contracted from 0.3× the prior year.
Humana P/S Ratio 2024: 0.3×
Humana (HUM) P/S ratio in 2024 was 0.3×, contracted from 0.5× the prior year.
Humana P/S Ratio 2023: 0.5×
Humana (HUM) P/S ratio in 2023 was 0.5×, contracted from 0.7× the prior year.
Humana P/S Ratio 2022: 0.7×
Humana (HUM) P/S ratio in 2022 was 0.7×, contracted from 0.7× the prior year.
Humana P/S Ratio 2021: 0.7×
Humana (HUM) P/S ratio in 2021 was 0.7×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of Humana (HUM), ranked by P/S ratio.
| 2.5× | |
| 2.1× | |
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.5×
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
Humana (HUM) Key Financials
Charts, filings, and peer comparison for every metric